A multi-center non-randomized, single-arm feasibility trial to build and validate technology platform to collect, analyze and co-register multi-modal data across time and sites. Patients will undergo standard of care therapy for brain tumor diagnosis. Patients will be assessed pre- and post-operatively using neuropsychological tests for language function and mental health. Data will retro- and prospectively collected and co-registered for the validation of the MindTrace platform.
